Mr. Y. Mark Xu, Chairman of Xynomic Pharma, will provide an update of its innovative oncology drug pipeline at the BioCentury China Healthcare Summit 2018.

From Startup Xynomic Pharma

Link to Full Article: http://xynomicpharma.com/en/1811-2/

Mr. Y. Mark Xu, Chairman of Xynomic Pharma, will provide an update of its innovative oncology drug pipeline at the BioCentury China Healthcare Summit 2018.

Mr. Xu will present at 12:55 pm on Tuesday, November 13, 2018 at Ballroom I, 5th Floor, Jing An Shangri-La Hotel, Shanghai, China.

BioCentury and BayHelix Present: The 5th China Healthcare Summit
China’s Globally Facing Future: How China’s healthcare pathfinders are leveraging the nation’s innovation, policy initiatives and access to capital markets in HK and domestic exchanges to build a globally facing industry. Five years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2018, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.
The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting.

Please visit their site for more information: Xynomic Pharma.com

All,Biotechnology,Healthcare News,Startup News
2018-11-08 21:38:19